Navigation Links
VIVUS Announces Sale of MUSE Assets to Meda
Date:10/4/2010

MOUNTAIN VIEW, Calif., Oct. 4 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma company - for MUSE®, transurethral alprostadil, for the treatment of erectile dysfunction (ED).  Under the agreement, Meda will acquire the MUSE assets including the United States and foreign MUSE patents, existing inventory and the manufacturing facility located in Lakewood, New Jersey.  As part of the transaction, the existing VIVUS employees that are MUSE dedicated, including the field sales force, are expected to join Meda. VIVUS will retain all of the liabilities associated with the pre-closing operations of the MUSE business.

"We have been business partners with Meda in Europe for MUSE since 2000 and the acquisition of MUSE fits with their expansion plans," stated Leland Wilson, chief executive officer of VIVUS.  "The divestiture of MUSE to Meda will allow us to focus on our commercialization efforts for QNEXA for obesity and development of avanafil for erectile dysfunction.  I appreciate all the efforts from those employees that have been involved with MUSE since its approval in late 1996.  As part of the Meda urology portfolio, we expect MUSE to continue to meet the needs of ED patients and their providers for years to come."

The acquisition price is $23.5 million, which includes an upfront cash payment of $22 million.  VIVUS is eligible to receive a one-time milestone payment of $1.5 million based on future sales of MUSE.  The transaction is subject to standard closing requirements and conditions.  The transaction is expected to close on or before November 15, 2010.

About MUSEIn 1997, VIVUS commercially launched MUSE in the United States. MUSE was the first minimally invasive therapy for erectile dysfunction app
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
2. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
3. VIVUS to Present at Lazard Capital Markets Healthcare Conference
4. VIVUS Announces Promotion of Peter Tam to President
5. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
6. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
7. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
8. NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients
9. Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever® in Japan
10. Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain
11. Nephros Completes Bridge Financing and Announces Stockholder Rights Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Minn. , March 5, 2015  ANI ... today announced that it has acquired the approved ... tablets USP 50mg, 100mg and 150mg, previously marketed ... overall market for this product was approximately $39 ... S. Przybyl , President and CEO of ANI ...
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "India Pharma Outlook 2015: Accelerating growth to the ... Generics" report to their offering. ... in the 2013 caused by the market,s reaction to ... expected to continue to be healthy, as the momentum ...
(Date:3/5/2015)... , March 5, 2015 Soligenix, Inc. (OTCQB: ... company committed to developing products that address unmet medical ... announced today that its President and Chief Executive Officer, ... corporate presentation at the 27 th Annual ROTH ... on Tuesday, March 10, 2015 at 1:00 PM Pacific ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
... 2011 Grifols, the Spanish group which specializes in the ... of plasma products, will shortly start construction of a new ... employ about 100 people, as soon as it obtains local ... to fractionate 1 million liters of plasma a year (with ...
... ALEXANDRIA, Va., Feb. 18, 2011 The National ... National Community Pharmacists Association (NCPA) have sent a ... State Medicaid Director, explaining the importance of pharmacies ... to work together to cut costs without endangering ...
Cached Medicine Technology:Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles) 2NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 2NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 3
(Date:3/5/2015)... HomeCEUConnection.com is proud to support Nutrition ... their nutrition CEUs. To raise awareness on ... is offering 10% off selected nutrition CEU ... . , High Quality Continuing Education for ... continuing education courses for Physical Therapists, Physical ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 In honor ... to shatter myths about drug and alcohol abuse in ... released a Fact Sheet with information on some of ... in 2010 by the National Institute on Drug Abuse, ... alcohol aims to counteract the illusions that teens and ...
(Date:3/5/2015)... Califia Farms , the leading producer of ... West that its popular ready-to-drink Vanilla and Chocolate Protein ... free. Califia Farms Vegan Protein Almondmilk drinks come in ... six grams of an innovative nutrient-dense, pea and sprouted ... magnesium. , Protein is an essential part of a ...
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has officially ... in the supply chain industry, and we are excited ... were included on this year’s list! Russ King and ... to their hard work, their commitment to excellence, and ... client needs and challenges. , Russ and ...
(Date:3/5/2015)... Harrisburg, NC (PRWEB) March 05, 2015 ... of Physician Assistants’ (AAPA) review of Clearstream, ... AAPA determined that Clearstream’s MediDefense line of products—led ... of the AAPA’s Affinity Partner Program. , The ... physician assistants across all medical and surgical specialties ...
Breaking Medicine News(10 mins):Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4
... genetic factors and drug abuse saying that genetic tendencies play ... ,Dr. Kenneth S. Kendler, who has led the ... the importance of genetic factors in a culture/country (Norway) with ... that in such countries, social rather than genetics factors should ...
... When the body's arteries, veins and capillaries become diseased, ... the possibility of stroke and heart attack.// Dennis Gable, ... Baylor Regional Medical Center at Plano, provides information about ... ,Varicose veins: ,Varicose veins are large, twisted, swollen ...
... person dying of coronary heart disease can be predicted by ... venules in the eyes. ,Arterioles and venules are ... reflects the general state of the smaller blood vessels in ... of the study, 78 women (just over 4%) and 114 ...
... be a wake up call to get the duvets washed and ... their duvets even in six months, and these could// be the ... ,A survey conducted in many households revealed that two ... months. The dust mites and filth are potential health hazards ...
... have said one therapeutic dose of radiation resulted in mice ... ,Research in US have indicated, in a study ... Physiology that mice that has received a single therapeutic dose ... of radiation received by human cancer patients lost as much ...
... NHS has launched National Transplant Week to raise awareness of ... take place and the number of people// awaiting transplants. ... population in Britain has joined the Organ Donor Register. In ... on transplant lists, only 2,200 actually operations took place. ...
Cached Medicine News:Health News:Vascular Disease 101: Discovering and Treating Common Diseases of the Veins 2Health News:National Transplant Week to Raise Need for Organ Donation 2
... hydroxyapatite (HA) orbital implant was conceived by ... 1980s, after a comprehensive review of the ... earliest manuscripts dating back to 1885 (Mules ... dissatisfaction with the performance of contemporary implants, ...
... Evisceration. The new MEDPOR PLUS ... MEDPOR Spheres with a bioactive glass ... throughout the sphere structure, promotes more ... PLUS sphere., ,MEDPOR is a biocompatible ...
... the TORIC ICL are posterior chamber phakic ... collagen copolymer, the lens rests behind the ... material contains a small amount of collagen, ... capability. The lens is gently folded and ...
... refractive lens technology for the phakic ... efficacy, demonstrates quality of vision and ... correction. The lens is compatible with ... now available for the correction of ...
Medicine Products: